Avery Therapeutics, Inc.
Avery Therapeutics is dedicated to developing immunomodulatory biologic therapeutics aimed at improving human life. The company focuses on creating novel treatments for diseases of aging, inflammation, and fibrosis through a unique immunomodulatory platform that redirects the immune system to restore organ function and enhance quality of life.
Industries
Nr. of Employees
small (1-50)
Avery Therapeutics, Inc.
Products
Investigational bioengineered epicardial patch (preclinical)
A tissue-engineered epicardial patch intended to modulate immune responses and promote cardiac repair following infarction; evaluated in swine and rodent preclinical models.
Investigational iPSC-derived cardiomyocyte patch (preclinical)
A cardiomyocyte-containing tissue construct derived from induced pluripotent stem cells designed to electrically couple with host myocardium and improve function in preclinical models.
Investigational bioengineered epicardial patch (preclinical)
A tissue-engineered epicardial patch intended to modulate immune responses and promote cardiac repair following infarction; evaluated in swine and rodent preclinical models.
Investigational iPSC-derived cardiomyocyte patch (preclinical)
A cardiomyocyte-containing tissue construct derived from induced pluripotent stem cells designed to electrically couple with host myocardium and improve function in preclinical models.
Services
End-to-end preclinical development including design, fabrication, and efficacy testing of immunomodulatory biologics and bioengineered patches in rodent and large-animal models.
CMC and manufacturing operations to support product development and regulatory readiness for cell- and tissue-based therapeutic candidates.
End-to-end preclinical development including design, fabrication, and efficacy testing of immunomodulatory biologics and bioengineered patches in rodent and large-animal models.
CMC and manufacturing operations to support product development and regulatory readiness for cell- and tissue-based therapeutic candidates.
Expertise Areas
- Immunomodulatory biologics
- Tissue engineering and biomaterials
- Cardiac regenerative medicine
- Preclinical large-animal and rodent studies
Key Technologies
- Immunomodulatory biologic platforms
- Bioengineered epicardial patches
- Induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs)
- Biomaterial scaffolds and matrix patches
News & Updates
A scientific article discussing a new approach to treating heart failure through immune modulation, authored by Jordan J. Lancaster and colleagues.
Research on a bioengineered epicardial patch that promotes macrophage-mediated repair in infarcted hearts.
A perspective article on developing a bioengineered patch for heart failure treatment.
Study on cardiac magnetic resonance imaging in a swine model of heart failure.
Research on bioengineered cardiomyocyte xenografts in a rat model.
A study on cell-based therapy for heart failure using engineered tissue.
A scientific article discussing a new approach to treating heart failure through immune modulation, authored by Jordan J. Lancaster and colleagues.
Research on a bioengineered epicardial patch that promotes macrophage-mediated repair in infarcted hearts.
A perspective article on developing a bioengineered patch for heart failure treatment.
Study on cardiac magnetic resonance imaging in a swine model of heart failure.
Research on bioengineered cardiomyocyte xenografts in a rat model.
A study on cell-based therapy for heart failure using engineered tissue.